6 results
C.2 SUNFISH parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 50 / Issue s2 / June 2023
- Published online by Cambridge University Press:
- 05 June 2023, pp. S51-S52
-
- Article
-
- You have access
- Export citation
Radiotherapy dose and survival outcomes in human papillomavirus positive oropharyngeal cancer
-
- Journal:
- The Journal of Laryngology & Otology / Volume 134 / Issue 6 / June 2020
- Published online by Cambridge University Press:
- 18 June 2020, pp. 533-540
- Print publication:
- June 2020
-
- Article
- Export citation
P.063 SUNFISH Part 1 results and Part 2 trial design in patients with type 2/3 spinal muscular atrophy (SMA) receiving risdiplam (RG7916)
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 46 / Issue s1 / June 2019
- Published online by Cambridge University Press:
- 05 June 2019, p. S31
-
- Article
-
- You have access
- Export citation
P.064 FIREFISH Part 1: 1-year results on motor function in infants with Type 1 spinal muscular atrophy (SMA) receiving risdiplam (RG7916)
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 46 / Issue s1 / June 2019
- Published online by Cambridge University Press:
- 05 June 2019, p. S31
-
- Article
-
- You have access
- Export citation
Regional Infection Control Assessment of Antibiotic Resistance Knowledge and Practice
-
- Journal:
- Infection Control & Hospital Epidemiology / Volume 36 / Issue 4 / April 2015
- Published online by Cambridge University Press:
- 13 January 2015, pp. 381-386
- Print publication:
- April 2015
-
- Article
- Export citation
Multi-pathogen waterborne disease outbreak associated with a dinner cruise on Lake Michigan
-
- Journal:
- Epidemiology & Infection / Volume 140 / Issue 4 / April 2012
- Published online by Cambridge University Press:
- 19 May 2011, pp. 621-625
-
- Article
-
- You have access
- HTML
- Export citation